These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24025354)

  • 21. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
    Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
    Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a TGF-β/SMAD/lnc-UTGF positive feedback loop and its role in hepatoma metastasis.
    Wu MZ; Yuan YC; Huang BY; Chen JX; Li BK; Fang JH; Zhuang SM
    Signal Transduct Target Ther; 2021 Nov; 6(1):395. PubMed ID: 34785655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer.
    Ye Q; Cai W; Zheng Y; Evers BM; She QB
    Oncogene; 2014 Apr; 33(14):1828-39. PubMed ID: 23624914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
    Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
    Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein.
    Yuan T; Chen Z; Yan F; Qian M; Luo H; Ye S; Cao J; Ying M; Dai X; Gai R; Yang B; He Q; Zhu H
    Mol Oncol; 2020 Jan; 14(1):197-210. PubMed ID: 31721429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smad7 induces hepatic metastasis in colorectal cancer.
    Halder SK; Rachakonda G; Deane NG; Datta PK
    Br J Cancer; 2008 Sep; 99(6):957-65. PubMed ID: 18781153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.
    Freeman TJ; Smith JJ; Chen X; Washington MK; Roland JT; Means AL; Eschrich SA; Yeatman TJ; Deane NG; Beauchamp RD
    Gastroenterology; 2012 Mar; 142(3):562-571.e2. PubMed ID: 22115830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
    Dong X; Liao W; Zhang L; Tu X; Hu J; Chen T; Dai X; Xiong Y; Liang W; Ding C; Liu R; Dai J; Wang O; Lu L; Lu X
    Cancer Lett; 2017 Aug; 402():153-165. PubMed ID: 28600110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant p53 disrupts role of ShcA protein in balancing Smad protein-dependent and -independent signaling activity of transforming growth factor-β (TGF-β).
    Lin S; Yu L; Yang J; Liu Z; Karia B; Bishop AJR; Jackson J; Lozano G; Copland JA; Mu X; Sun B; Sun LZ
    J Biol Chem; 2011 Dec; 286(51):44023-44034. PubMed ID: 22039050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGF beta-induced focal complex formation in epithelial cells is mediated by activated ERK and JNK MAP kinases and is independent of Smad4.
    Imamichi Y; Waidmann O; Hein R; Eleftheriou P; Giehl K; Menke A
    Biol Chem; 2005 Mar; 386(3):225-36. PubMed ID: 15843168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
    Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
    J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LINC00941 promotes CRC metastasis through preventing SMAD4 protein degradation and activating the TGF-β/SMAD2/3 signaling pathway.
    Wu N; Jiang M; Liu H; Chu Y; Wang D; Cao J; Wang Z; Xie X; Han Y; Xu B
    Cell Death Differ; 2021 Jan; 28(1):219-232. PubMed ID: 32737443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smad4 inactivation promotes malignancy and drug resistance of colon cancer.
    Papageorgis P; Cheng K; Ozturk S; Gong Y; Lambert AW; Abdolmaleky HM; Zhou JR; Thiagalingam S
    Cancer Res; 2011 Feb; 71(3):998-1008. PubMed ID: 21245094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SMAD4/DPC4 expression and prognosis in human colorectal cancer.
    Isaksson-Mettävainio M; Palmqvist R; Forssell J; Stenling R; Oberg A
    Anticancer Res; 2006; 26(1B):507-10. PubMed ID: 16739311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PRMT5 methylating SMAD4 activates TGF-β signaling and promotes colorectal cancer metastasis.
    Liu A; Yu C; Qiu C; Wu Q; Huang C; Li X; She X; Wan K; Liu L; Li M; Wang Z; Chen Y; Hu F; Song D; Li K; Zhao C; Deng H; Sun X; Xu F; Lai S; Luo X; Hu J; Wang G
    Oncogene; 2023 May; 42(19):1572-1584. PubMed ID: 36991117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AGO1 may influence the prognosis of hepatocellular carcinoma through TGF-β pathway.
    Wang M; Zhang L; Liu Z; Zhou J; Pan Q; Fan J; Zang R; Wang L
    Cell Death Dis; 2018 Feb; 9(3):324. PubMed ID: 29487329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
    Huang G; Du MY; Zhu H; Zhang N; Lu ZW; Qian LX; Zhang W; Tian X; He X; Yin L
    Biomed Pharmacother; 2018 Oct; 106():217-224. PubMed ID: 29960168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
    Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
    World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 40. Decreased tumor progression and invasion by a novel anti-cell motility target for human colorectal carcinoma cells.
    Jin Q; Liu G; Domeier PP; Ding W; Mulder KM
    PLoS One; 2013; 8(6):e66439. PubMed ID: 23755307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.